Mounjaro weight loss trials have also been conducted on obese, non-diabetic patients [14]
As clinicians, we like solid evidence-based [interventions]. Working holistically GLP-1 agonists, which are more commonly known by popular brand names, Ozempic and Wegovy, are injectable medications that mimic glucagon-like peptide-1, a natural hormone secreted in response to food intake that slows digestion and gives the brain satiety signals
Bailey et al., Canadian Medical Association Journal , 2013 (grapefruit-drug interactions)
Retatrutide , a triple agonist targeting GLP-1, GIP, and glucagon receptors, has shown even more dramatic weight loss in clinical trials, with some participants losing over 25% of their body weight
D., Miranda-Diaz, A